Related Experiment Videos
Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica
S J Hawthorne1, M Pagano, D W Halton
1Biomedicinal Chemistry Group, School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland.
Abstract:
A 30-kDa protease, purified previously from Fasciola hepatica, was sequenced and the first 15 N-terminal residues were found to be 100% homologous to a region in the protein Fcp1c, which was cloned and expressed from F. hepatica. This terminal region was also 53 and 54% identical to two other cathepsin L-like proteases isolated from the same source. The 30-kDa protease demonstrated a specificity different from humancathepsin L when assayed with novel peptidyl enediones of the type Z-Phe-Ala-CH&dbond;CH(2)-CO(2)R (where R = Me/Et/Bu(t)). The ethyl ester peptide was a more efficient inhibitor of the protease than the corresponding methyl ester. This is in contrast to bovine cathepsin B and human cathepsin L where both are more readily inhibited by the methyl, rather than the ethyl ester peptide. These differences in the inhibition of the novel parasite protease may allow it to be exploited as a chemotherapeutic target.
Insights
Researchers identified a novel protease from Fasciola hepatica, showing unique inhibition patterns. This parasite protease
Area of Science:
- Biochemistry
- Parasitology
- Drug Discovery
Background:
- Fasciola hepatica, a liver fluke, causes significant parasitic infections.
- Proteases play crucial roles in parasite survival and pathogenesis.
- Understanding parasite-specific proteases is key for developing targeted therapies.
Purpose of the Study:
- To characterize a 30-kDa protease isolated from Fasciola hepatica.
- To investigate the enzyme's substrate specificity and inhibition profile.
- To explore its potential as a chemotherapeutic target.
Main Methods:
- Protein sequencing of the 30-kDa protease.
- Homology analysis with known cathepsin L-like proteases.
- Enzyme inhibition assays using novel peptidyl enediones.
Main Results:
- The N-terminal sequence showed high homology to Fasciola hepatica protein Fcp1c.
- The protease exhibited distinct substrate specificity compared to human cathepsin L.
- Ethyl ester peptidyl enediones were more effective inhibitors than methyl esters, unlike human cathepsin L and bovine cathepsin B.
Conclusions:
- The 30-kDa Fasciola hepatica protease is a distinct enzyme with unique inhibition characteristics.
- These differences suggest potential for selective inhibition.
- The protease represents a promising chemotherapeutic target for treating Fasciola hepatica infections.